# ADMELOG

NDC: 70518-4275
Generic name: insulin lispro
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250204

FDA application: BLA209196

## Active ingredients

- INSULIN LISPRO: 100 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-4275"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-4275
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ec9e3f-e2ac-43a1-b334-8b6538cf2bb0